<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The multifunctional receptor LRP1 controls expression, activity and trafficking of the PDGF receptor-beta in vascular smooth muscle cells (VSMC) </plain></SENT>
<SENT sid="1" pm="."><plain>LRP1 is also a receptor for TGFbeta1 and is required for TGFbeta mediated inhibition of cell proliferation </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS AND PRINCIPAL FINDINGS: We show that loss of LRP1 in VSMC (smLRP(-)) in vivo results in a Marfan-like syndrome with nuclear accumulation of phosphorylated Smad2/3, disruption of elastic layers, <z:e sem="disease" ids="C0741171" disease_type="Disease or Syndrome" abbrv="">tortuous aorta</z:e>, and increased expression of the TGFbeta target genes thrombospondin-1 (TSP1) and PDGFRbeta in the vascular wall </plain></SENT>
<SENT sid="3" pm="."><plain>Treatment of smLRP1(-) animals with the PPARgamma <z:chebi fb="4" ids="48705">agonist</z:chebi> <z:chebi fb="0" ids="50122">rosiglitazone</z:chebi> abolished nuclear pSmad accumulation, reversed the Marfan-like phenotype, and markedly reduced smooth muscle proliferation, <z:mp ids='MP_0003045'>fibrosis</z:mp> and <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> independent of plasma cholesterol levels </plain></SENT>
<SENT sid="4" pm="."><plain>CONCLUSIONS AND SIGNIFICANCE: Our findings are consistent with an activation of TGFbeta signals in the LRP1-deficient vascular wall </plain></SENT>
<SENT sid="5" pm="."><plain>LRP1 may function as an integrator of proliferative and anti-proliferative signals that control physiological mechanisms common to the pathogenesis of <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> and <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo>, and this is essential for maintaining vascular wall integrity </plain></SENT>
</text></document>